These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16753157)

  • 1. Optimal stimulation protocols for in vitro fertilization.
    Muasher SJ; Abdallah RT; Hubayter ZR
    Fertil Steril; 2006 Aug; 86(2):267-73. PubMed ID: 16753157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH antagonists in ovarian stimulation for IVF.
    Tarlatzis BC; Fauser BC; Kolibianakis EM; Diedrich K; Rombauts L; Devroey P
    Hum Reprod Update; 2006; 12(4):333-40. PubMed ID: 16567347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH antagonists.
    Coccia ME; Comparetto C; Bracco GL; Scarselli G
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115 Suppl 1():S44-56. PubMed ID: 15196716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development.
    Lainas TG; Petsas GK; Zorzovilis IZ; Iliadis GS; Lainas GT; Cazlaris HE; Kolibianakis EM
    Hum Reprod; 2007 Jun; 22(6):1540-6. PubMed ID: 17347165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovulation induction in IVF.
    Oehninger S
    Minerva Ginecol; 2011 Apr; 63(2):137-56. PubMed ID: 21508903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of repeated spontaneous luteinizing hormone surges in ovarian stimulation for in vitro fertilization.
    Nisker JA; Bloch CL; Tummon IS; Daniel SA; Yuzpe AA
    J Reprod Med; 1993 Jun; 38(6):413-6. PubMed ID: 8331617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are GnRH antagonists comparable to agonists for use in IVF?
    Huirne JA; Homburg R; Lambalk CB
    Hum Reprod; 2007 Nov; 22(11):2805-13. PubMed ID: 17872909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.
    Devroey P; Aboulghar M; Garcia-Velasco J; Griesinger G; Humaidan P; Kolibianakis E; Ledger W; Tomás C; Fauser BC
    Hum Reprod; 2009 Apr; 24(4):764-74. PubMed ID: 19153090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates.
    Acevedo B; Gomez-Palomares JL; Ricciarelli E; Hernández ER
    Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GnRH agonists vs antagonists.
    Tarlatzis BC; Kolibianakis EM
    Best Pract Res Clin Obstet Gynaecol; 2007 Feb; 21(1):57-65. PubMed ID: 17049460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH antagonist in in vitro fertilization: where we are now.
    Shapiro DB; Mitchell-Leef D
    Minerva Ginecol; 2003 Oct; 55(5):373-88. PubMed ID: 14581880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ovarian stimulation for IVF in France: choice and results according to protocols and gonadotrophin].
    Rossin B; Pouly JL; Belaisch-Allart J; de Mouzon J;
    Gynecol Obstet Fertil; 2009; 37(11-12):864-72. PubMed ID: 19833539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry.
    Griesinger G; Felberbaum R; Diedrich K
    Hum Reprod; 2005 Sep; 20(9):2373-5. PubMed ID: 15932915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis.
    Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Baart EB; Hohmann FP; Fauser BC; Broekmans FJ
    Hum Reprod Update; 2009; 15(1):5-12. PubMed ID: 19091754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?
    Orvieto R; Meltzer S; Rabinson J; Gemer O; Anteby EY; Nahum R
    Fertil Steril; 2008 Oct; 90(4):1297-300. PubMed ID: 18249369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of LH in controlled ovarian stimulation.
    Wiesak T
    Reprod Biol; 2002 Nov; 2(3):215-27. PubMed ID: 14666146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coasting and ovarian stimulation protocols in high-responder patients undergoing assisted conception].
    Merviel P; Claeys C; Héraud MH; Lourdel E; Lanta S; Barbier F; Nasreddine A
    Gynecol Obstet Fertil; 2005 Sep; 33(9):703-12. PubMed ID: 16129645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of gonadotropin-releasing hormone antagonists in poor responders.
    Mahutte NG; Arici A
    Fertil Steril; 2007 Feb; 87(2):241-9. PubMed ID: 17113088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GnRH agonist and GnRH antagonist in intracytoplasmic injection cycles.
    Rashid MR; Ong FB; Omar MH; Ng SP; Nurshaireen A; Sharifah-Teh NS; Fazilah AH; Zamzarina MA
    Med J Malaysia; 2008 Jun; 63(2):113-7. PubMed ID: 18942295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.